ERBB2 and breast cancer: Moreover, high levels of GSDMB decrease sensitivity to trastuzumab in vitro in HCC1954 and SKBR3 cells, and its expression increases during the acquisition of trastuzumab resistance in HER2 + breast cancer PDX models [12].